Global Wearable Medical Devices Market Predicted to Reach $185 Billion by 2032
October 1, 2025 | Globe NewswireEstimated reading time: 4 minutes
The global wearable medical devices market is experiencing rapid growth, driven by the increasing burden of chronic diseases, the adoption of remote patient monitoring, and swift technological progress. Equipped with compact sensors, AI-powered analytics, and 5G connectivity, these devices are transitioning from simple fitness trackers to vital healthcare tools that enable proactive and connected care.
DelveInsight’s Wearable Medical Devices Market Insights report provides the current and forecast market analysis, individual leading wearable medical devices companies’ market shares, challenges, wearable medical devices market drivers, barriers, trends, and key market wearable medical devices companies in the market.
Wearable Medical Devices Market Summary
- The global wearable medical devices market is expected to increase from USD 43 billion in 2024 to USD 185 billion by 2032, reflecting strong and sustained growth.
- The global wearable medical devices market is expected to grow at a CAGR of ~20% during the forecast period from 2025 to 2032.
- The leading companies working in the wearable medical devices market include Apple Inc., Alphabet Inc., Samsung Electronics Co., Ltd., Garmin Ltd., Koninklijke Philips N.V., Medtronic, Abbott Laboratories, Dexcom, Inc., Boston Scientific Corporation, OMRON Corporation, ResMed, Becton, Dickinson and Company, iRhythm Technologies, Inc., Withings, Vital Connect, Inc., Masimo Corporation, Insulet Corporation, Zoll Medical Corporation, Biotricity Inc., Nuvo Group, Ypsomed, and others.
- Among all the regions, North America is anticipated to register the fastest growth in the wearable medical devices market during the forecast period.
- In the product type segment of the wearable medical devices market, the diagnostic & monitoring devices category accounted for the largest market share in 2024.
Key Factors Contributing to the Rise in Growth of the Wearable Medical Devices Market
Increasing Prevalence of Chronic Diseases
Rising cases of cardiovascular disorders, diabetes, respiratory conditions, and other chronic illnesses are driving demand for continuous monitoring solutions, where wearable devices play a vital role.
Shift Toward Preventive and Personalized Healthcare
Consumers and healthcare providers are increasingly prioritizing preventive care and personalized health management, where wearables offer real-time data and actionable insights.
Technological Advancements
Improvements in sensor technologies, miniaturization, battery life, wireless connectivity, and integration with AI/ML are enhancing device accuracy, usability, and appeal.
Rising Health Awareness and Fitness Trends
Consumers are more health-conscious, driving adoption of fitness trackers, smartwatches, and wearable biosensors that bridge the gap between lifestyle devices and medical-grade equipment.
Integration with Telehealth and Remote Patient Monitoring
The expansion of telemedicine, especially post-COVID-19, has accelerated the demand for connected devices that enable remote patient monitoring and reduce hospital visits.
Regulatory Approvals and Expanding Clinical Applications
Increasing FDA and CE clearances for medical-grade wearables (e.g., ECG, glucose monitoring, arrhythmia detection) are broadening clinical adoption and trust in these devices.
Regional Wearable Medical Devices Market Insights
In 2024, North America, driven primarily by the U.S., commanded nearly 43% of the global wearable medical devices market. This dominance is supported by robust healthcare infrastructure, high healthcare spending per capita, and a strong innovation ecosystem. Growth is being propelled by the dual adoption of clinical-grade devices in hospitals and consumer-focused wearables, many of which are now gaining FDA approvals for medical use, increasingly bridging consumer health with clinical care. The U.S. continues to serve as a hub for technological advancements and reimbursement-backed uptake of remote monitoring solutions.
Europe is establishing itself as a significant growth region for wearable medical devices, supported by both mature healthcare systems and the expanding use of home healthcare solutions. Market expansion is driven by the region’s aging demographics, rising prevalence of chronic illnesses, and government initiatives in digital health, including Germany’s DiGA framework and the EU’s European Health Data Space (EHDS) project.
The Asia-Pacific region is anticipated to register the fastest expansion, with a striking CAGR of 24.7%. Growth here is fueled by its large population base, increasing middle-class healthcare expenditure, and the highest global prevalence of diabetes and hypertension. Governments in China, India, Japan, and South Korea are prioritizing digital health development, strengthening telemedicine networks, and encouraging local manufacturing of wearables, which is driving down costs and accelerating adoption. Widespread smartphone usage and affordable data connectivity further support mHealth integration, while regional startups and tech giants are rapidly innovating in AI-powered diagnostics and connected healthcare platforms. Consequently, APAC is emerging not only as a key growth engine but also as a potential trendsetter in shaping cost-effective, scalable, and technology-driven healthcare delivery.
Recent Developmental Activities in the Wearable Medical Devices Market
In May 2025, Masimo Corporation received FDA 510(k) clearance for its Masimo W1 watch. This approval expanded the watch's indications to include continuous and spot-check measurements of heart rate and oxygen saturation (SpO2), making it a viable option for a range of clinical settings.
In April 2025, WHOOP, Inc. obtained FDA clearance for its WHOOP ECG feature. This clearance validates the feature's ability to provide a single-lead electrocardiogram, enabling it to detect and provide notifications for certain heart rhythm irregularities. This approval represents a significant step for a consumer-grade device moving into a more medical-focused space
In April 2025, VitalConnect, Inc. received FDA 510(k) clearance for its VitalRhythm biosensor. The approval validates the device's ability to continuously monitor and record an ECG, heart rate, and respiratory rate, enhancing its utility for remote patient monitoring.
Wearable Medical Devices Overview
Wearable medical devices are transforming healthcare by enabling continuous monitoring, real-time data collection, and proactive disease management outside of traditional clinical settings. These devices, which include smartwatches, biosensors, fitness trackers, and implantable wearables, can track vital signs such as heart rate, blood pressure, oxygen saturation, glucose levels, and even sleep patterns. By providing clinicians and patients with actionable health insights, wearable technology supports early diagnosis, personalized treatment, and improved adherence to care plans. The integration of artificial intelligence and wireless connectivity further enhances their utility, making remote patient monitoring and telemedicine more effective.
Testimonial
"Our marketing partnership with I-Connect007 is already delivering. Just a day after our press release went live, we received a direct inquiry about our updated products!"
Rachael Temple - AlltematedSuggested Items
NEOTech Celebrates Sixth Mexico Technology Award Win for Outstanding EMS Services Over $100M
09/19/2025 | NEOTechNEOTech, a leading provider of electronic manufacturing services (EMS), design engineering, and supply chain solutions in the high-tech industrial, medical device, and aerospace/defense markets, is proud to announce that it has once again earned the prestigious Mexico Technology Award in the category of EMS Services > $100 Million.
Medical Device OEM/ODM/CDMO Industry Forecast: CAGR of 7.5% to 2031 Amid Growing Healthcare Innovation
09/17/2025 | PRNewswireThe global market for Medical Device OEM/ODM/CDMO was valued at US$ 115434 million in the year 2024 and is projected to reach a revised size of US$ 191760 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
09/15/2025 | GlobeNewswireArmstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories across 7 countries in Asia, has signed a Memorandum of Understanding (MOU) with Checkmate Capital Group, LLC (“Checkmate Capital”), a U.S.-based investment and advisory firm active in the Asia-Pacific and North American regions, focused on cross-border transactions in the life sciences, medical technology, and other industries.
Nordson MEDICAL Divests Contract Manufacturing, Refocuses on Proprietary Components
09/03/2025 | BUSINESS WIRENordson Corporation has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical.
Medical Device Contract Manufacturing Market Worth $140.84 Billion by 2030 with 10.9% CAGR
08/25/2025 | PRNewswireThe global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.